Clinical Trial Update: Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

View source ↗

Summary

Leuko Labs, Inc. is conducting a pivotal study to validate a novel non-invasive system for detecting severe neutropenia. The trial covers Diffuse Large B-Cell L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Multiple Myeloma

Snippet

Sponsor: Leuko Labs, Inc. | Conditions: Diffuse Large B Cell Lymphoma, Multiple Myeloma | Status: NOT_YET_RECRUITING